Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.

Gorlov IP, Gallick GE, Gorlova OY, Amos C, Logothetis CJ.

PLoS One. 2009 Aug 4;4(8):e6511. doi: 10.1371/journal.pone.0006511.

2.

Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer.

Jia P, Liu Y, Zhao Z.

BMC Syst Biol. 2012;6 Suppl 3:S13. doi: 10.1186/1752-0509-6-S3-S13. Epub 2012 Dec 17.

3.

Prioritizing genes associated with prostate cancer development.

Gorlov IP, Sircar K, Zhao H, Maity SN, Navone NM, Gorlova OY, Troncoso P, Pettaway CA, Byun JY, Logothetis CJ.

BMC Cancer. 2010 Nov 2;10:599. doi: 10.1186/1471-2407-10-599.

4.

Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression.

Zhao H, Logothetis CJ, Gorlov IP.

Prostate Cancer Prostatic Dis. 2010 Sep;13(3):252-9. doi: 10.1038/pcan.2010.9. Epub 2010 Apr 13.

5.

Integrative biology of prostate cancer progression.

Tomlins SA, Rubin MA, Chinnaiyan AM.

Annu Rev Pathol. 2006;1:243-71. Review.

PMID:
18039115
6.

Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.

Arencibia JM, Martín S, Pérez-Rodríguez FJ, Bonnin A.

Int J Oncol. 2009 Feb;34(2):457-63.

PMID:
19148481
7.

Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome.

Woltmann A, Chen B, Lascorz J, Johansson R, Eyfjörd JE, Hamann U, Manjer J, Enquist-Olsson K, Henriksson R, Herms S, Hoffmann P, Hemminki K, Lenner P, Försti A.

PLoS One. 2014 Jun 2;9(6):e98229. doi: 10.1371/journal.pone.0098229. eCollection 2014.

8.

Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.

Shaikhibrahim Z, Lindstrot A, Langer B, Buettner R, Wernert N.

Int J Mol Med. 2011 Jun;27(6):811-9. doi: 10.3892/ijmm.2011.652. Epub 2011 Mar 21.

PMID:
21424114
9.

Discovery of prostate cancer biomarkers by microarray gene expression profiling.

Sørensen KD, Ørntoft TF.

Expert Rev Mol Diagn. 2010 Jan;10(1):49-64. doi: 10.1586/erm.09.74. Review.

PMID:
20014922
10.

Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.

Shan J, Al-Rumaihi K, Rabah D, Al-Bozom I, Kizhakayil D, Farhat K, Al-Said S, Kfoury H, Dsouza SP, Rowe J, Khalak HG, Jafri S, Aigha II, Chouchane L.

J Transl Med. 2013 May 13;11:121. doi: 10.1186/1479-5876-11-121.

11.
12.

A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.

Williams KA, Lee M, Hu Y, Andreas J, Patel SJ, Zhang S, Chines P, Elkahloun A, Chandrasekharappa S, Gutkind JS, Molinolo AA, Crawford NP.

PLoS Genet. 2014 Nov 20;10(11):e1004809. doi: 10.1371/journal.pgen.1004809. eCollection 2014 Nov. Erratum in: PLoS Genet. 2015 May;11(5):e1005127.

13.

Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Gregg JL, Brown KE, Mintz EM, Piontkivska H, Fraizer GC.

BMC Cancer. 2010 Apr 28;10:165. doi: 10.1186/1471-2407-10-165.

14.

Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.

Lu Y, Sun J, Kader AK, Kim ST, Kim JW, Liu W, Sun J, Lu D, Feng J, Zhu Y, Jin T, Zhang Z, Dimitrov L, Lowey J, Campbell K, Suh E, Duggan D, Carpten J, Trent JM, Gronberg H, Zheng SL, Isaacs WB, Xu J.

Prostate. 2012 Mar;72(4):376-85. doi: 10.1002/pros.21439. Epub 2011 Jun 10.

15.

EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.

Kim YJ, Yoon HY, Kim SK, Kim YW, Kim EJ, Kim IY, Kim WJ.

Clin Cancer Res. 2011 Jul 1;17(13):4523-30. doi: 10.1158/1078-0432.CCR-10-2817. Epub 2011 May 13.

16.

Prostate cancer and the genomic revolution: Advances using microarray analyses.

Calvo A, Gonzalez-Moreno O, Yoon CY, Huh JI, Desai K, Nguyen QT, Green JE.

Mutat Res. 2005 Aug 25;576(1-2):66-79. Review.

PMID:
15950992
18.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
19.

Search for cancer risk factors with microarray-based genome-wide association studies.

Zhang L, Zhang W, Chen K.

Technol Cancer Res Treat. 2010 Apr;9(2):107-21. Review.

PMID:
20218734
20.

Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.

Kamradt J, Jung V, Wahrheit K, Tolosi L, Rahnenfuehrer J, Schilling M, Walker R, Davis S, Stoeckle M, Meltzer P, Wullich B.

PLoS One. 2007 Aug 22;2(8):e769.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk